92 related articles for article (PubMed ID: 19123479)
1. Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine.
Colombo F; Falvella FS; De Cecco L; Tortoreto M; Pratesi G; Ciuffreda P; Ottria R; Santaniello E; Cicatiello L; Weisz A; Dragani TA
Int J Cancer; 2009 May; 124(9):2179-85. PubMed ID: 19123479
[TBL] [Abstract][Full Text] [Related]
2. Novel isopentenyladenosine analogues: synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells.
Ottria R; Casati S; Maier JA; Mariotti M; Ciuffreda P
Nucleosides Nucleotides Nucleic Acids; 2009 Aug; 28(8):736-51. PubMed ID: 20183613
[TBL] [Abstract][Full Text] [Related]
3. N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells.
Castiglioni S; Casati S; Ottria R; Ciuffreda P; Maier JA
Anticancer Agents Med Chem; 2013 May; 13(4):672-8. PubMed ID: 23094912
[TBL] [Abstract][Full Text] [Related]
4. N6-isopentenyladenosine: a potential therapeutic agent for a variety of epithelial cancers.
Spinola M; Colombo F; Falvella FS; Dragani TA
Int J Cancer; 2007 Jun; 120(12):2744-8. PubMed ID: 17304507
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity of N(6)-isopentenyladenosine on HCT-15 colon carcinoma cell line.
Rajabi M; Mehrzad J; Gorincioi E; Santaniello E
Nucleic Acid Ther; 2011 Oct; 21(5):355-8. PubMed ID: 22004416
[TBL] [Abstract][Full Text] [Related]
6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
8. Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug.
Bifulco M; Malfitano AM; Proto MC; Santoro A; Caruso MG; Laezza C
Anticancer Agents Med Chem; 2008 Feb; 8(2):200-4. PubMed ID: 18288922
[TBL] [Abstract][Full Text] [Related]
9. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.
Ranieri R; Ciaglia E; Amodio G; Picardi P; Proto MC; Gazzerro P; Laezza C; Remondelli P; Bifulco M; Pisanti S
Cell Death Differ; 2018 Feb; 25(2):353-367. PubMed ID: 29027991
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative activity of N6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study.
Rajabi M; Signorelli P; Gorincioi E; Ghidoni R; Santaniello E
DNA Cell Biol; 2010 Nov; 29(11):687-91. PubMed ID: 20818975
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives.
Ottria R; Casati S; Manzocchi A; Baldoli E; Mariotti M; Maier JA; Ciuffreda P
Bioorg Med Chem; 2010 Jun; 18(12):4249-54. PubMed ID: 20494583
[TBL] [Abstract][Full Text] [Related]
12. Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
Höpfner M; Sutter AP; Beck NI; Barthel B; Maaser K; Jockers-Scherübl MC; Zeitz M; Scherübl H
Int J Cancer; 2002 Sep; 101(3):210-6. PubMed ID: 12209970
[TBL] [Abstract][Full Text] [Related]
13. 6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest.
Zhang P; Chen JH; Dong X; Tang MT; Gao LY; Zhao GS; Yu LG; Guo XL
Biomed Pharmacother; 2013 Feb; 67(1):58-65. PubMed ID: 23201007
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
16. N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1.
Laezza C; Caruso MG; Gentile T; Notarnicola M; Malfitano AM; Di Matola T; Messa C; Gazzerro P; Bifulco M
Int J Cancer; 2009 Mar; 124(6):1322-9. PubMed ID: 19058178
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of natural cytokinins: a structure-activity relationship study.
Voller J; Zatloukal M; Lenobel R; Dolezal K; Béres T; Krystof V; Spíchal L; Niemann P; Dzubák P; Hajdúch M; Strnad M
Phytochemistry; 2010 Aug; 71(11-12):1350-9. PubMed ID: 20553699
[TBL] [Abstract][Full Text] [Related]
18. Antisense-protein kinase A: a single-gene-based therapeutic approach.
Cho-Chung YS; Nesterova M; Kondrashin A; Noguchi K; Srivastava R; Pepe S
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):217-23. PubMed ID: 9212914
[No Abstract] [Full Text] [Related]
19. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
20. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A
Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
